Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    22837004 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Research In Viral Eradication of HIV Reservoirs
Condition: HIV
Interventions: Drug: Combination Antiretroviral Therapy (cART);   Drug: Raltegravir;   Drug: Vorinostat;   Biological: ChAdV63.HIVconsv (ChAd);   Biological: MVA.HIVconsv (MVA)
2 Not yet recruiting Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Condition: HIV
Intervention: Biological: HXTC infusion
3 Recruiting A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
Condition: HIV
Intervention: Biological: AGS-004
4 Recruiting The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
Condition: HIV-1 Infection
Intervention: Drug: Vorinostat

Indicates status has not been verified in more than two years